<DOC>
	<DOCNO>NCT02783495</DOCNO>
	<brief_summary>This pilot trial iPad-based intervention glioma patient University California , San Francisco ( UCSF ) establish feasibility preliminary efficacy data support funding application large clinical trial . Twenty patient stable low-grade glioma complete computerized battery standardize neurocognitive test quality life assessment baseline . Subjects complete intervention home 3 month . Neuro-cognitive testing repeat 3 9 month baseline . Subjects also complete post-intervention questionnaire usefulness , attractiveness , difficulty burden intervention . Clinical data collect time assessment . This include diagnostic treatment history , magnetic resonance imaging ( MRI data ) , tumor genomics immunohistochemistry .</brief_summary>
	<brief_title>Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor Patients</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Patients must histologically confirm WHO grade 2 3 glioma . Patients must &gt; 18 year old Patients must life expectancy &gt; 12 week . Patients must Karnofsky performance status &gt; 70 . This study design include woman minority , design measure difference . Males female recruit preference gender . Minorities actively recruit participate . No exclusion study base race . Patients must speak able read English fluently . All patient must sign informed consent indicate aware investigational nature study . Patients must sign authorization release protect health information . Patients may know HIVpositive . HIV test require study participation . Patients must history cancer ( except nonmelanoma skin cancer carcinoma insitu cervix ) , unless complete remission therapy disease minimum 3 year . Patients must receive MRI scan UCSF Patients must clinically stable treatment ( e.g . radiation chemotherapy ) ≥ 6 month Patients must ≥ 6 month craniotomy Patients must subjective complaint cognitive deficit . Patients must adequate seizure control stable , decrease , dose antiepileptic Patients able comply study and/or followup procedure . Patients home access Internet . Patients , base physician 's opinion , unable participate neurocognitive test and/or neurocognitive rehab secondary significant neurologic deficit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>glioma</keyword>
	<keyword>neurocognitive</keyword>
	<keyword>quality life</keyword>
</DOC>